Company · CIK 1786255
Icosavax, Inc.
| CIK | 1786255 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | WA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-09-13 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-266894 | 2022-08-16 | 2024-02-20 | 4 | |
| 333-257733 | 2021-07-07 | 2021-07-30 | 4 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-02-20 | EFFECTDeclared effective | 333-266894 | 9999999995-24-000493 |
| 2023-05-23 | 424B5Shelf takedown | 333-266894 | 0001193125-23-151014 |
| 2022-08-29 | EFFECTDeclared effective | 333-266894 | 9999999995-22-002540 |
| 2022-08-16 | S-3Shelf registered | 333-266894 | 0001193125-22-221436 |
| 2021-07-30 | 424B4Final prospectus | 333-257733 | 0001193125-21-229444 |
| 2021-07-28 | EFFECTDeclared effective | 333-257733 | 9999999995-21-002961 |
| 2021-07-22 | S-1/AAmendment | 333-257733 | 0001193125-21-221834 |
| 2021-07-07 | S-1Registration filed | 333-257733 | 0001193125-21-209031 |
| 2021-05-14 | DRSDraft made public | 377-04875 | 0000950123-21-006606 |